![](/img/cover-not-exists.png)
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment
Tinazzi, E., Puccetti, A., Gerli, R., Rigo, A., Migliorini, P., Simeoni, S., Beri, R., Dolcino, M., Martinelli, N., Corrocher, R., Lunardi, C.Volume:
21
Language:
english
Journal:
International Immunology
DOI:
10.1093/intimm/dxn142
Date:
January, 2009
File:
PDF, 241 KB
english, 2009